Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
PaperCitations, authors & open-access status
Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 883 citations, 2016 year and green oa status.
883
Citations
2016
Year
green
OA Status